From The Archives – In Search of a Competitive Advantage: A Primer for the Clinician Treating the Anabolic Steroid User

January 26, 2017
From The Archives – In Search of a Competitive Advantage: A Primer for the Clinician Treating the Anabolic Steroid User

Please enjoy this post from the archives dated, April 17, 2013

By David G. Rosenthal and Robert Gianotti, MD

Faculty Peer Reviewed

Case: A 33-year-old man comes to your clinic complaining of worsening acne over the last 6 months. You note a significant increase in both BMI and bicep circumference. After several minutes of denial, he reveals that he has been using both injectable and oral anabolic steroids. He receives these drugs from a local supplier and via the Internet. He confides that his libido …

Read more »

Optimism

January 25, 2017
Optimism

By Adam Blaisdell, MD

Peer Reviewed

Present Day – The patient is a 61 year-old male who presents with a one-week history of jaundice and intense pruritus. He has a medical history significant for hepatitis C virus (HCV) infection (genotype 1a) diagnosed 15 years ago, which was never treated. Three years prior, the patient was also diagnosed with hepatocellular carcinoma (HCC) and underwent transcatheter arterial chemoembolization (TACE) but was subsequently lost to follow-up. He has no documented evidence of cirrhosis. On this admission his total …

Read more »

Primecuts – This Week In The Journals

January 24, 2017
Primecuts – This Week In The Journals

Lee,Chang W. – from camera serial number NYTCREDIT: Chang W. Lee/The New York Times

By Calvin Ngai, MD

Peer Reviewed

In former President Barack Obama’s last farewell speech, he asked all fellow Americans to continue to believe in our ability to create change. This past weekend, the day after Donald J. Trump was sworn into the presidential office and our country bid one last farewell to former President Obama, hundreds of thousands of women gathered in Washington D.C. (millions, including marches from all around the …

Read more »

Gamechanger? Can Pioglitazone Reduce Cardiovascular Events After a Stroke? An Analysis of the IRIS Trial

January 19, 2017
Gamechanger?  Can Pioglitazone Reduce Cardiovascular Events After a Stroke?  An Analysis of the IRIS Trial

By Johanna Hase, MD

Peer Reviewed

Welcome to Gamechangers, a series that takes a critical look at the latest in medical literature to answer one important question: would the results of this article change my practice? Featuring thorough evidence-based review as well as expert commentary, our aim is for this series to help you decide if the results of a given study are, in fact, a gamechanger

A 64 year old woman with pre-diabetes, hyperlipidemia, and hypertension on aspirin, losartan and simvastatin, recently was diagnosed …

Read more »

Primecuts – This Week In The Journals

January 17, 2017
Primecuts – This Week In The Journals

By Scott Butler, MD 

Peer Reviewed

A presidential goodbye. A contentious press conference.  A salacious dossier from a British spy.  It’s been quite a week.

As Republican legislators transition from symbolically voting to repeal Obamacare (over 50 times since its inception) to making its dissolution a reality, it becomes increasingly clear that “replace” is the much more challenging half of the promise to “repeal and replace” the law. Theodore Roosevelt backed a plan for universal coverage when he sought an elusive third term in 1912.  …

Read more »

Myths and Realities: Is My Cirrhotic Patient Auto-anticoagulated?

January 12, 2017
Myths and Realities: Is My Cirrhotic Patient Auto-anticoagulated?

By B. Corbett Walsh, MD

Peer Reviewed

Case: A 65 year-old man with cirrhosis is admitted to the ICU for severe pneumonia. His hepatic dysfunction is chronically severe, as indicated by a MELD score of 31, and he has a stable thrombocytopenia of 110,000 platelets/ml. Should this patient be on DVT prophylaxis?

MYTH: Patients with severe hepatic dysfunction resulting in a significantly elevated INR are auto-anticoagulated and protected against venous thromboembolic events.

The liver is responsible for a plethora of processes: metabolic (carbohydrate and lipid …

Read more »

Primecuts – This Week In The Journals

January 9, 2017
Primecuts – This Week In The Journals

By: Nancyanne Schmidt, MD

Peer Reviewed

This week, the intelligence report commissioned by President Obama on suspected hacking during the recent presidential election revealed that Russian President Vladimir Putin ordered an influence campaign aimed at undermining The Democratic National Committee and Hillary Clinton’s campaign, in particular. The report, which compiled the collective assessments of the C.I.A., National Security Agency and F.B.I., stopped short of implicating Russia in the outcome of the recent presidential election in which President-elect Donald Trump defeated Hillary Clinton in a …

Read more »

Primecuts – This Week In The Journals

January 4, 2017
Primecuts – This Week In The Journals

By Derek Moriyama, MD

Peer Reviewed 

It is official. The members of the electoral college have cast their votes and Donald Trump will be the next President of the United States. As he continues to use twitter as a platform to inform the world of his beliefs, including a reference to the direction of our nuclear program , we are all left guessing how his Presidency will affect the future of our country and the world.

Aside from U.S. political news, there have been shocking …

Read more »